Are You Ready To Pitch To Investors? Enter the RESI Europe Innovators’ Pitch Challenge

14 Feb

By Karen Deyo, Investor Research Analyst, LSN

LSN first introduced the Innovators’ Pitch Challenge at RESI Boston in September of 2018. This new aspect of RESI was designed to give the earliest stage companies spinning out from incubators, accelerators and universities a platform to pitch to a panel of investors.  The aim of the RESI Innovators’ Pitch Challenge was to give these companies a chance to practice their investment pitch and get valuable feedback from real investors. To get a perspective on the value of participating in the Innovators’ Pitch Challenge, I spoke to Scott Stout, CEO of MedVector Clinical Trials (one of the companies selected to participate in the West Coast Innovators’ Pitch Challenge at RESI San Francisco), and Ravi Mistry, an angel investor part of TiE Silicon Valley Angels, who was part of the investor panel at the same event.

Especially for those earliest stage companies just starting their first major fundraise, the ability to practice your pitch before a panel of investors can be helpful. The questions asked by the experienced investor panelists can help the participants anticipate what investors will ask when pitching to them, as well as helping you identify what areas of your pitch may need to be clarified. As an angel investor and very active mentor for entrepreneurs, Ravi pointed out how valuable an exercise this can be, both as a way to potentially catch the interest of the investor panelists, as well as a practice for the future. Ravi also noted that the diverse range of expertise the investors had, across all sectors of the life sciences, can be helpful to the exercise.

Beyond the value of practicing his pitch, Scott said that one of the major benefits of applying to and participating in the Pitch Challenge was the additional exposure he received via RESI’s website and on-site guide, and the ability to highlight to current and potential investors that their company was selected to participate by LSN’s scientific review team. This serves as valuable external validation of the company and technology.

To apply for the European Innovators’ Pitch Challenge, please fill out the application and make sure to indicate that you are a tech hub constituent!

Accelerating clinical trials speeds up medicine. MedVector is a turnkey solution using telemedicine to increase clinical trial participation, generate revenue for hospitals, reduce costs to clinical trial sponsors, and bring life-saving, advanced medicine to market more quickly.

Ravi Mistry, Member, TiE Angels

Ravi Mistry is a leader, entrepreneur, angel investor, educator and mentor. His professional career has spanned the life sciences, technology, non-profits, and academics as Founder, Board Chairman/Director, President, Vice President, Sr. Director, Manager, and Adjunct Professor. He brings experience covering all areas of business operations. He has managed closing of Seed, Series A/B funding totaling over $35M. Ravi served as VP/BizDev at MedTree, a life sciences start-up, and as Executive Director of Indian Institute of Technology Gandhinagar Foundation to raise endowment funds. Previously, Ravi was member of founding team of Virident Systems, a technology startup acquired by HGST/Western Digital. Ravi has held management positions in the life sciences companies DiscoveRx (acquired by Eurobond) and BioImagene (acquired by Roche). He is Gold Medalist from Gujarat University, India, with a bachelor’s degree in Engineering. He received his Master’s in Engineering from Stanford, and an MBA in Finance from CSUEB.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: